{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T12:51:05Z","timestamp":1764334265623,"version":"3.46.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100013826","name":"Candys Foundation","doi-asserted-by":"publisher","award":["2020-352-14024-1"],"award-info":[{"award-number":["2020-352-14024-1"]}],"id":[{"id":"10.13039\/501100013826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001734","name":"Copenhagen University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001734","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"DOI":"10.1186\/s13063-025-09074-4","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T12:46:50Z","timestamp":1764334010000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploring the salivary proteome following intraglandular mesenchymal stromal cell therapy for radiation-induced hyposalivation in previous head and neck cancer patients: a secondary study protocol for the MESRIX-III, randomised, controlled trial"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-3840-8083","authenticated-orcid":false,"given":"Amanda-Louise Fenger","family":"Carlander","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathrine Kronberg","family":"Jakobsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Jersie-Christensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone Kloch","family":"Bendtsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Kastrup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Belstr\u00f8m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte Duch","family":"Lynggard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Gr\u00f8nh\u00f8j","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"von Buchwald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"issue":"3","key":"9074_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"9074_CR2","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.radonc.2015.04.021","volume":"116","author":"JM Borras","year":"2015","unstructured":"Borras JM, Barton M, Grau C, Corral J, Verhoeven R, Lemmens V, et al. The impact of cancer incidence and stage on optimal utilization of radiotherapy: methodology of a population based analysis by the ESTRO-HERO project. Radiother Oncol. 2015;116(1):45\u201350.","journal-title":"Radiother Oncol"},{"key":"9074_CR3","doi-asserted-by":"crossref","unstructured":"Vissink A, Burlage FR, Spijkervet FK, Jansma J, Coppes RP. Prevention and treatment of the consequences of head and neck radiotherapy. Critical Reviews in Oral Biology and Medicine. 2003;14(3):213\u201325.","DOI":"10.1177\/154411130301400306"},{"issue":"22","key":"9074_CR4","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.1200\/JCO.2007.14.6647","volume":"26","author":"JA Langendijk","year":"2008","unstructured":"Langendijk JA, Doornaert P, Verdonck-de Leeuw IM, Leemans CR, Aaronson NK, Slotman BJ. Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy. J Clin Oncol. 2008A;26(22):3770\u20136.","journal-title":"J Clin Oncol"},{"issue":"3","key":"9074_CR5","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1177\/154411130301400305","volume":"14","author":"A Vissink","year":"2003","unstructured":"Vissink A, Jansma J, Spijkervet FKL, Burlage FR, Coppes RP. Oral sequelae of head and neck radiotherapy. Crit Rev Oral Biol Med. 2003;14(3):199\u2013212.","journal-title":"Crit Rev Oral Biol Med"},{"key":"9074_CR6","doi-asserted-by":"publisher","first-page":"171","DOI":"10.2147\/TCRM.S70652","volume":"11","author":"R Pinna","year":"2015","unstructured":"Pinna R, Campus G, Cumbo E, Mura I, Milia E. Xerostomia induced by radiotherapy: an overview of the physiopathology, clinical evidence, and management of the oral damage. Ther Clin Risk Manag. 2015;11:171\u201388.","journal-title":"Ther Clin Risk Manag"},{"issue":"3","key":"9074_CR7","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1177\/154411130301400306","volume":"14","author":"A Vissink","year":"2003","unstructured":"Vissink A, Burlage FR, Spijkervet FKL, Jansma J, Coppes RP. Prevention and treatment of the consequences of head and neck radiotherapy. Crit Rev Oral Biol Med. 2003;14(3):213\u201325.","journal-title":"Crit Rev Oral Biol Med"},{"key":"9074_CR8","doi-asserted-by":"crossref","unstructured":"Jensen SB, Pedersen AM, Vissink A, Andersen E, Brown CG, et al. Salivary Gland Hypofunction\/Xerostomia Section, Oral Care Study Group, Multinational Association of Supportive Care in Cancer (MASCC)\/International Society of Oral Oncology (ISOO). A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life. Support Care Cancer. 2010;18(8):1039\u201360.","DOI":"10.1007\/s00520-010-0827-8"},{"issue":"3","key":"9074_CR9","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.ijrobp.2007.04.021","volume":"69","author":"AP Jellema","year":"2007","unstructured":"Jellema AP, Slotman BJ, Doornaert P, Leemans CR, Langendijk JA. Impact of radiation-induced xerostomia on quality of life after primary radiotherapy among patients with head and neck cancer. Int J Radiat Oncol Biol Phys. 2007;69(3):751\u201360.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"9074_CR10","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.oooo.2013.11.496","volume":"117","author":"DH Jensen","year":"2014","unstructured":"Jensen DH, Oliveri RS, Trojahn K\u00f8lle SF, Fischer-Nielsen A, Specht L, Bardow A, et al. Mesenchymal stem cell therapy for salivary gland dysfunction and xerostomia: a systematic review of preclinical studies. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;117(3):335-342.e1.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"7","key":"9074_CR11","first-page":"CD012744","volume":"7","author":"P Riley","year":"2017","unstructured":"Riley P, Glenny AM, Hua F, Worthington HV. Pharmacological interventions for preventing dry mouth and salivary gland dysfunction following radiotherapy. Cochrane Database Syst Rev. 2017;7(7):CD012744.","journal-title":"Cochrane Database Syst Rev."},{"key":"9074_CR12","doi-asserted-by":"crossref","unstructured":"Jensen SB, Vissink A, Limesand KH, Reyland ME. Salivary Gland Hypofunction and Xerostomia in Head and Neck Radiation Patients. J Natl Cancer Inst Monogr. 2019;2019(53):lgz016.","DOI":"10.1093\/jncimonographs\/lgz016"},{"key":"9074_CR13","doi-asserted-by":"crossref","unstructured":"Carlander ALF, Gundestrup AK, Jansson PM, Follin B, Hoeeg C, Kousholt BS, et al. Mesenchymal stromal\/stem cell therapy improves salivary flow rate in radiation-induced salivary gland hypofunction in preclinical in vivo models: a systematic review and meta-analysis. Stem Cell Rev Rep. 2024;20(4):1078\u201392.","DOI":"10.1007\/s12015-024-10700-y"},{"issue":"13","key":"9074_CR14","doi-asserted-by":"publisher","first-page":"2890","DOI":"10.1158\/1078-0432.CCR-21-4520","volume":"28","author":"CD Lynggaard","year":"2022","unstructured":"Lynggaard CD, Gr\u00f8nh\u00f8j C, Jensen SB, Christensen R, Specht L, Andersen E, et al. Long-term safety of treatment with autologous mesenchymal stem cells in patients with radiation-induced xerostomia: primary results of the MESRIX phase I\/II randomized trial. Clin Cancer Res. 2022;28(13):2890\u20137.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"9074_CR15","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.ijrobp.2018.02.034","volume":"101","author":"C Gr\u00f8nh\u00f8j","year":"2018","unstructured":"Gr\u00f8nh\u00f8j C, Jensen DH, Vester-Glowinski P, Jensen SB, Bardow A, Oliveri RS, et al. Safety and efficacy of mesenchymal stem cells for radiation-induced xerostomia: a randomized, placebo-controlled phase 1\/2 trial (MESRIX). Int J Radiat Oncol Biol Phys. 2018;101(3):581\u201392.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"9074_CR16","doi-asserted-by":"crossref","unstructured":"Jakobsen K, Carlander ALF, Todsen T, Melchiors J, Paaske N, \u00d8stergaard Madsen AK, et al. Mesenchymal stem\/stromal cell therapy for radiation-induced xerostomia in previous head and neck cancer patients: a phase 2 randomised, placebo-controlled trial. Clin Cancer Res. 2024;30(10):2078\u201384.","DOI":"10.1158\/1078-0432.CCR-23-3675"},{"issue":"5","key":"9074_CR17","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1093\/stcltm\/szac011","volume":"11","author":"CD Lynggaard","year":"2022","unstructured":"Lynggaard CD, Gr\u00f8nh\u00f8j C, Christensen R, Fischer-Nielsen A, Melchiors J, Specht L, et al. Intraglandular off-the-shelf allogeneic mesenchymal stem cell treatment in patients with radiation-induced xerostomia: a safety study (MESRIX-II). Stem Cells Transl Med. 2022;11(5):478\u201389.","journal-title":"Stem Cells Transl Med"},{"issue":"1","key":"9074_CR18","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/s43856-022-00223-3","volume":"2","author":"CD Lynggaard","year":"2022","unstructured":"Lynggaard CD, Jersie-Christensen R, Juhl M, Jensen SB, Gr\u00f8nh\u00f8j C, Melchiors J, et al. Intraglandular mesenchymal stem cell treatment induces changes in the salivary proteome of irradiated patients. Communications medicine. 2022;2(1):160.","journal-title":"Communications medicine"},{"issue":"1","key":"9074_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13063-023-07594-5","volume":"24","author":"KK Jakobsen","year":"2023","unstructured":"Jakobsen KK, Carlander ALF, Gr\u00f8nh\u00f8j C, Todsen T, Melchiors J, Paaske N, et al. Effectiveness and safety of mesenchymal stem\/stromal cell for radiation-induced hyposalivation and xerostomia in previous head and neck cancer patients (MESRIX-III): a study protocol for a single-centre, double-blinded, randomised, placebo-controlled, phase II study. Trials. 2023;24(1):1\u20139.\u00a0Available from:\u00a0https:\/\/doi.org\/10.1186\/s13063-023-07594-5.","journal-title":"Trials."},{"issue":"3","key":"9074_CR20","doi-asserted-by":"publisher","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","volume":"158","author":"AW Chan","year":"2013","unstructured":"Chan AW, Tetzlaff JM, Altman DG, Laupacis A, G\u00f8tzsche PC, Krle\u017ea-Jeri\u0107 K, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158(3):200\u20137.","journal-title":"Ann Intern Med"},{"issue":"14","key":"9074_CR21","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1093\/bioinformatics\/btu153","volume":"30","author":"T Seemann","year":"2014","unstructured":"Seemann T. Prokka: rapid prokaryotic genome annotation. Bioinformatics. 2014;30(14):2068\u20139.","journal-title":"Bioinformatics"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-09074-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-025-09074-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-09074-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T12:46:55Z","timestamp":1764334015000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-025-09074-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["9074"],"URL":"https:\/\/doi.org\/10.1186\/s13063-025-09074-4","relation":{},"ISSN":["1745-6215"],"issn-type":[{"type":"electronic","value":"1745-6215"}],"subject":[],"published":{"date-parts":[[2025,11,28]]},"assertion":[{"value":"5 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Lynggaard, Gr\u00f8nh\u00f8j and von Buchwald are co-inventors on patent application for \u201cStem cell therapy for patients with salivary gland dysfunction\u201d, PCT\/EP2020\/053878, owned by Rigshospitalet, Copenhagen University Hospital and University of Copenhagen. Kastrup, Ekblond and Haack-S\u00f8rensen hold a patent application for the investigated stem cell product \u201cStem cell therapy based on adipose-derived stem cells\u201d, WO2017068140 owned by Rigshospitalet, Copenhagen University Hospital and Capital Region of Denmark. All the other co-authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"554"}}